Anne W. Schmidt

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

David W. Schulz, Robert S. Mansbach, Jeffrey Sprouse et al. · Proceedings of the National Academy of Sciences · 1996 · 378 citations · Full text

Social Sciences, Molecular Pharmacology, Crf Receptors +17

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 320 citations

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

Anne W. Schmidt, Lorraine A. Lebel, Harry Howard et al. · European Journal of Pharmacology · 2001 · 288 citations

Psychoactive Drug, Psychiatry, Medicine +9

Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 <i>H</i> -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).

Patrick R. Verhoest, Douglas S. Chapin, Michael L. Corman et al. · Journal of Medicinal Chemistry · 2009 · 201 citations · Full text

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

Hans Rollema, Yi Lu, Anne W. Schmidt et al. · European Journal of Pharmacology · 1997 · 199 citations

Neuropsychology, Psychoactive Drug, Psychiatry +11